Evidence map›Paper›PMID 29849702›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2018

Effect of Allicin against Ischemia/Hypoxia-Induced H9c2 Myoblast Apoptosis via eNOS/NO Pathway-Mediated Antioxidant Activity.

Lina Ma, Shangke Chen, Shaochun Li, Lijuan Deng, Yikui Li, Hao Li

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
5.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Potential Antidote Against Lead Toxicity-A Review.International journal of molecular sciences · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lina MaXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.ORCID 0000-0001-7935-1548
Shangke ChenXinjiang Ailexin Pharmaceutical Co., Ltd., Urumqi, Xinjiang, China.ORCID 0000-0002-8457-8613
Shaochun LiXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.ORCID 0000-0002-4149-7274
Lijuan DengXinjiang Ailexin Pharmaceutical Co., Ltd., Urumqi, Xinjiang, China.ORCID 0000-0001-9535-0940
Yikui LiXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.ORCID 0000-0002-7449-9786
Hao LiXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.ORCID 0000-0001-8502-2556
Chinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allicin (2-propene-1-sulfinothioic acid

Identifiers

PMID29849702
PMCPMC5926492
OpenAlexW2800389042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.